Literature DB >> 21640215

The forkhead transcription factor Foxc2 promotes osteoblastogenesis via up-regulation of integrin β1 expression.

Su Jin Park1, Jogeswar Gadi, Kyoung-Won Cho, Kwang Joon Kim, Se Hwa Kim, Han-Sung Jung, Sung-Kil Lim.   

Abstract

The forkhead box C2 (Foxc2) protein, a member of the forkhead/winged helix transcription factor family, plays an important role in regulation of metabolism, arterial specification, and vascular sprouting. Foxc2-null mutants die prenatally or perinatally, and they exhibit hypoplasia of the vertebrae and insufficient chondrification or ossification of medial structures. However, the role of Foxc2 in osteoblastogenesis is not yet fully understood. According to the degree of differentiation of osteoblasts, we found that Foxc2 expression was gradually increased and dose-dependently up-regulated by well-known bone anabolic agents, such as hPTH(1-34) and BMP2. In ex vivo mouse calvarial organ culture, a significant reduction of the basal expression of Foxc2 induced by siFoxc2 remarkably suppressed cell proliferation and differentiation and induced cell death. Knockdown of Foxc2 expression using siFoxc2 in both MC3T3-E1 and primary mouse calvarial cells also resulted in a significant suppression of proliferation and differentiation, and induced cell death, supporting the ex vivo observations. In addition, the resistance to apoptosis induced by serum deprivation and phosphorylation of both Akt and ERK was significantly reduced after siFoxc2 treatment. Conversely, overexpression of Foxc2 increased the proliferation of MC3T3-E1 and primary mouse calvarial cells. Furthermore, we found that Foxc2 enhanced the expression of integrin β1, an important modulator of osteoblastogenesis, by direct binding to a Forkhead-binding element in its promoter. Taken together, these results indicate that Foxc2 plays an important role in osteoblastogenesis by promoting osteoblast proliferation, survival and differentiation through up-regulation of integrin β1 in response to stimuli which induce bone formation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640215     DOI: 10.1016/j.bone.2011.05.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

1.  Foxc2 over-expression in bone marrow mesenchymal stem cells stimulates osteogenic differentiation and inhibits adipogenic differentiation.

Authors:  Wulin You; Lihong Fan; Dapeng Duan; Lei Tian; Xiaoqian Dang; Chunsheng Wang; Kunzheng Wang
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

Review 2.  Targeting integrins to promote bone formation and repair.

Authors:  Pierre J Marie
Journal:  Nat Rev Endocrinol       Date:  2013-01-29       Impact factor: 43.330

3.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

4.  Combining Foxc2 and Connexin37 deletions in mice leads to severe defects in lymphatic vascular growth and remodeling.

Authors:  John D Kanady; Stephanie J Munger; Marlys H Witte; Alexander M Simon
Journal:  Dev Biol       Date:  2015-06-14       Impact factor: 3.582

5.  FOXC2 promotes colorectal cancer metastasis by directly targeting MET.

Authors:  Y-M Cui; H-L Jiao; Y-P Ye; C-M Chen; J-X Wang; N Tang; T-T Li; J Lin; L Qi; P Wu; S-Y Wang; M-R He; L Liang; X-W Bian; W-T Liao; Y-Q Ding
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

6.  Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway.

Authors:  Fei-Xiang Lin; Shi-Xin Du; De-Zhong Liu; Qin-Xiao Hu; Guo-Yong Yu; Chu-Cheng Wu; Gui-Zhou Zheng; Da Xie; Xue-Dong Li; Bo Chang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 7.  Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.

Authors:  Kristian M Hargadon; Travis B Goodloe; Nathaniel D Lloyd
Journal:  Cancer Metastasis Rev       Date:  2022-06-14       Impact factor: 9.264

8.  Next-Generation Sequencing of Circular RNAs Reveals the Molecular Mechanisms of Chondrogenic Differentiation in Human Adipose-derived Stem Cells.

Authors:  Simin Luo; Wuji Li; Wenrui Wu; Qiping Shi
Journal:  Cell Biochem Biophys       Date:  2022-03-07       Impact factor: 2.989

9.  The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.

Authors:  Peggy Benisch; Tatjana Schilling; Ludger Klein-Hitpass; Sönke P Frey; Lothar Seefried; Nadja Raaijmakers; Melanie Krug; Martina Regensburger; Sabine Zeck; Thorsten Schinke; Michael Amling; Regina Ebert; Franz Jakob
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

10.  Actin microfilament mediates osteoblast Cbfa1 responsiveness to BMP2 under simulated microgravity.

Authors:  Zhongquan Dai; Feng Wu; Jian Chen; Hongjie Xu; Honghui Wang; Feima Guo; Yingjun Tan; Bai Ding; Jinfu Wang; Yumin Wan; Yinghui Li
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.